LEGAL NOTICE: This information represents the most current product information available and may not include globally approved information. If you require information regarding any particular region or country, please contact the commercial area at the following email address info@inosanbiopharma.com

THE ANTIVENOM COMPANY™

We produce the latest generation
of highly specific biological polyvalent antivenoms

This could be the new Treatment developed in Mexico to neutralize COVID

To stop anyone from suffering or dying as a consequence of animal envenoming
OUR MISSION
We believe that no one should suffer or die as a consequence of animal envenoming. For this reason, we have developed a unique and original platform to make safe, effective, and non-cold chain dependent antivenoms available at a fair price.

We are eager to be part of the solution. We work close to patients along with the medical community, governments, and many international organizations and institutions in order to improve the access to antivenoms and the care for people affected by animal envenoming.
We currently distribute and commercialize our products mainly in Africa and Middle East and we are developing new antivenoms for other regions.

We perform our mission passionately and committed to the integrity wherever we operate. We reflect these values in our products, services, and communication while interacting with people.
Our strategy and products are aligned with the WHO plan to reduce the effects of animal envenoming.
OUR PRODUCTS
At Inosan Biopharma we develop and distribute
the latest generation antivenoms that meet the
highest manufacturing standards
  • Broad regional coverage of medically important species
  • Highly purified
  • High neutralizing capacity with low total protein content
  • No preservatives
  • Injectable lyophilizates
Technology driven solutions for the present and constantly evolving for the future.
At Inosan Biopharma, we have transformed antiserum to very pure antigen-binding immunoglobulin fragments with high neutralizing potency in full compliance with international GMPs requirements.
THE TEAM
Juan López de Silanes Blanco
CEO & Founder
Juan López de Silanes y Pérez
Chairman of the board & Founder
Beatriz López de Silanes Blanco
General Counsel & Chief
Compliance Officer
An independent family company.
We care for people, especially those affected by animal envenoming all around the world.
Raúl Soria
VP & COO
Always close to your community sharing our knowledge and training the future experts
4
MAR
Venom Week
March 4-7, 2020
Gainesville
26
MAR
ACAME
March 26-28, 2020
Ouagadougou (Burkina Faso)
25
AGO
Venom & Toxins
August 25 & 26, 2020
Oxford (UK)
2
DEC
ASV congress
Dec 2-5, 2020
Douala (Cameroon): the congress of the
African Society of Venimology
PROJECTS CLOSEST TO OUR HEARTS
Snakebites are ‘neglected’ health crisis in Africa
Snakebites kill tens of thousands of Africans a year. Now, an antivenom shortage is spurring global experts to collaborate on treatment and prevention.
Inosan Biopharma
Since our founding we've been working hand by hand with global institutions to bring solutions to communities affected by animal envenoming.
Asclepius Snakebite Foundation
Huge thank you to Inosan Biopharma for donating 200 vials of Inoserp Panafrica polyvalent antivenom to the Asclepius Snakebite Foundation
WHAT´S NEW?
Snakebites are ‘neglected’ health crisis in Africa
Snakebites kill tens of thousands of Africans a year. Now, an antivenom shortage is spurring global experts to collaborate on treatment and prevention.
Inosan Biopharma at the IST 2019
The world in which Inosan Biopharma was created presented a challenge: many pharmaceutical companies.
THE REALITY OF SNAKEBITES – TIME IS TISSUE
With at least 600,000 people worldwide killed or permanently disabled each year, snakebites are the biggest public health crisis that no one has heard of
UCSF Fresno Doctor Studies Venomics for Snakebite Treatment
Ever since he was a little boy, reptiles have fascinated UCSF Fresno emergency physician and medical toxicologist Nicklaus Brandehoff, MD
LANCEMENT D’UNE ÉTUDE AU CAMEROUN POUR ÉVALUER LES SÉRUMS ANTIVENIMEUX
L’étude « Morsures de serpent au Cameroun : Evaluation de Sérum Antivenimeux en Afrique (ESAA) relevé de données en condition de vie réelle
Poisonous animal bites, a public health problem in Mexico
In the current scenario, accidents caused by poisonous animals are already considered a public health problem in Mexico.
Do's and Don'ts in Case of Ophidic Accident
Do you know what to do if you are bitten by a snake? There are many myths about it and in these two minutes Dr. Luis Eduardo Robles Ortíz, MD.

Contact us

España

Arbea Campus Empresarial
Edificio 2, Planta 2
Ctra. Fuencarral a Alcobedas km 3,8
28108 Alcobendas (Madrid),España
Tel. (+34) 913 346031

México

Lucerna 7, Col. Juárez
Ciudad de México, Mexico
(+52) 55 51 40 1535
info@inosanbiopharma.com

With representation in
USA, France, Ghana and Kenya